AT-1501-A201

· Anelixis Therapeutics, LLC

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AT-1501-A201, covering 2023-06-28 to 2023-06-28. Get the full timeline:

Most recent: Clinical Trial Update: Multiple Doses of AT-1501-A201 in Adults With ALS [Phase 2]